Table 3.
Independent risk factors for AKI in critically ill children and young adults with suspected SARS-CoV2 infection.
Relative risks | p-value | |
---|---|---|
Age category | ||
<5 years | Reference | |
5–13 years | 1.1 (0.8–1.6) | 0.5 |
≥13 years | 0.6 (0.4–1.1) | 0.09 |
Gender | ||
Male | 1.2 (0.9–1.6) | 0.3 |
Female | Reference | |
Race | ||
Black | 1.5 (0.7–3.0) | 0.3 |
White | Reference | |
Ethnicity | ||
Hispanic | 0.7 (0.4–1.2) | 0.19 |
Not-Hispanic | Reference | |
Presence of Comorbidities | 0.9 (0.6–1.3) | 0.6 |
Healthy | Reference | |
Admission diagnosis | ||
CNS-related | 0.4 (0.1–0.9) | 0.03 |
Not CNS-related | Reference | |
Vasopressor use | 1.4 (0.9–2.0) | 0.10 |
No vasopressor use | Reference | |
Invasive respiratory Support | 1.3 (0.9–1.9) | 0.11 |
No invasive respiratory support | Reference |
The above data demonstrate the relative risks versus embedded reference value for the association of SARS-CoV2 infection with the outcome of AKI.
Variables in the model included center, age category, gender, race, ethnicity, presence or absence of comorbidities, CNS (central nervous system)-associated admission diagnosis, invasive respiratory use, and vasopressor use.